The largest association of medical doctors and students in the US, the American Medical Association (AMA)—which represents over 228,000 current healthcare providers—will decide in the coming weeks whether to publicly support the AllTrials campaign for clinical trial transparency in the US.
From The Economist: The evidence base for new medications is flawed. Time to fix it.
From the Financial Times: Dozens of big investors have backed a campaign by British activists for more transparency in the pharmaceuticals industry.
From WSJ’s Pharmalot: In an unprecedented move, a group of 85 asset managers and pension funds is teaming with a U.K. non-profit campaign to pressure drug makers to disclose clinical trial data.
Cornell Alliance for Science: Sense About Science USA partnership offers statistical consultation for journalists
Cornell Alliance for Science sat down with Trevor Butterworth, Director of Sense About Science (SAS) USA based in NYC, to learn more about this new organization and its stateside vision and plans.
Bleacher Report Blog: The Columbia Journalism Review wrote about Trevor Butterworth last week, as this blog did in October. Butterworth is, as CJR describes him in its headline, “the man who wants to help journalists with numbers.”
Columbia Journalism Review: Like many champions of a fledgling idea, Trevor Butterworth has a big vision. He talks about revolutions—a revolution in big data, a revolution in exposing bad science, a revolution in journalism.
Wiley: Sense About Science, an independent trust founded in the UK to demand evidence behind scientific claims, has recently launched a US presence. We learned more from new US director, and former journalist, Trevor Butterworth.
GovLab: How safe are MMR vaccines, really? Will the highway next to my house increase my risk of asthma? All of these questions have major implications for key public policy decisions, and for citizens to answer them confidently, they need to be able to receive and understand well-founded scientific information.